StopDown
Funding · 16 June 2026TruNativ$30MHealth and wellness nutrition brandtrunativ.co ↗

TruNativ raises $30m in Series B led by OrbiMed

By · Editor ·

Series BMumbaiFounded 2019
  • TruNativ sells sugar substitutes, protein powders, and gut health supplements to Indian consumers
  • The company raised $30 million in a Series B round led by healthcare firm OrbiMed on June 16, 2026
  • Revenue grew from ₹37 crore to ₹130 crore as the startup targets international expansion and new product labs

What happened

  • TruNativ raised $30 million in a Series B funding round announced on June 16, 2026.
  • OrbiMed, a global healthcare investment firm, served as the lead investor for this transaction.
  • The capital mix included primary capital for growth and secondary share sales where early investors exited.
  • Early investors including 100Unicorns, Rainmatter, and Venture Catalysts completely exited their stakes.
  • Emami's stake was diluted from 19% to 10% during this financing event.
  • Dr. Sunny Sharma and Sumona Chakraborty from OrbiMed joined the board of directors.
  • The company reported ₹130 crore in revenue for FY26, up significantly from ₹37 crore the previous year.
  • TruNativ aims to reach ₹200 crore in revenue by FY27 with long-term goals of ₹800–1,000 crore.

Why it matters

  • India is identified as the diabetes and heart disease capital, driving demand for healthier alternatives.
  • The India protein market is estimated at $1.62 billion in 2026 with steady growth projections.
  • The startup landscape includes 2,672 nutrition-focused food startups, indicating a competitive but growing sector.
  • The company operates at breakeven while prioritizing aggressive growth over immediate profitability.

The business

  • TruNativ offers products in sugar substitutes, protein, gut health, beauty wellness, and performance nutrition.
  • Flagship items include Everyday Sweet (monk fruit substitute) and Everyday Protein (heat-stable for cooking).
  • The brand also sells Pro Blend Whey, Everyday Fiber, and Advanced Collagen supplements.
  • It runs a B2B2C ingredient business supplying nutrition solutions via its 'Mark of Good' programme.
  • Monthly orders range between 7–10 lakh with a 45% repeat purchase rate.
  • Sales are split equally across website, quick commerce, and ecommerce channels.
  • The company plans to launch an innovation centre called 'The Good Lab' in Mumbai for R&D.
  • Distribution will expand nationwide through D2C, modern trade, pharmacy, and retail outlets.
  • HORECA partnerships will place supplements in hotel rooms, conferences, and restaurant menus.

The founders

Pranav Malhotra

Co-Founder and CEO
  • Founded TruNativ in 2019 alongside his mother and a partner.

Mamta Malhotra

Co-Founder
  • Co-founded the company in 2019 with her son Pranav Malhotra.

Eeshaan Merchant

Co-Founder
  • Joined as a co-founder when TruNativ was established in 2019.

Who put in money

  • OrbiMed lead — Global healthcare investment firm providing capital and board representation.

In numbers

₹130 croreRevenue FY26 · 2026
~₹125 croreRevenue FY25 · 2025
₹37 croreRevenue FY24 · 2024
₹200 croreFY27 Revenue Target · 2027
₹800–1,000 croreLong-term Revenue Target · 2029-2031
7–10 lakhMonthly Orders
45%Repeat Purchase Rate
$1.62BMarket Size (Protein) · 2026
$2.22BMarket Size (Protein Forecast) · 2031

What happens next

  • Expand nationwide distribution across D2C, quick commerce, modern trade, pharmacy, and retail channels.
  • Scale the B2B2C ingredient business to supply more consumer brands.
  • Launch 'The Good Lab' innovation centre in Mumbai for research and development.
  • Enter international markets in Dubai and Singapore by the end of 2026.
  • Pursue HORECA partnerships to place products in hotels, conferences, and restaurants.

Earlier rounds

  • 2026-06-16 · Series B · $30M · led by OrbiMed

Up against

The Whole Truth FoodsOZivaWellbeing NutritionThe Good MonkSuperYouProtein ChefCosmix

Words to know

Secondary share sales
Existing shareholders sell their shares to new investors; no new money reaches the company.
Primary capital
New money invested directly into the company to fund operations and growth.
B2B2C
Business-to-Business-to-Consumer model where a company supplies ingredients to other brands that sell to end users.
HORECA
An acronym for Hotel, Restaurant, and Catering industry sectors.

The numbers around it

Commerce & Consumer Brands in June 2026: 24 rounds with a disclosed amount, $298 million in all; the biggest was FirstClub ($55M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on TruNativ → · All startup news on 16 June 2026 →

Is this TruNativ? Get your “Featured on StopDown” badge →